Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by Monaco21on Sep 15, 2020 8:12pm
182 Views
Post# 31564743

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Summer sale sold out Bioteck

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Summer sale sold out Bioteck

This is alright Biotek, honestly at this point I don’t think anyone expects much from your comments. Sernova is leading groundbreaking research and their science speaks for itself. Negative comments are clouds that are easily dispersed with facts, data and results. But, as I said, growth and pharma deals take time and most investors seem to understand this, but you. 


Your comments:  


“There were non dilutive options but management sucks at deal making” Broad and unsubstantiated statement. This seems to be your trend and that’s okay. Management has led extensive research and collaborations over the years and continues to do so, but I suppose it’s easier for you to say they “suck at deal making”.



“Instead they choose the easy and most destructive route”. You mean, they choose to fund the research? They choose to raise capital to continue working towards more extensive collaborations? I fail to see the destructiveness of management choices.


“ Everyone was crying and telling me I was stupid for thinking a PP was coming” well.. We didn't say this about you (but thank you for saying it yourself!).


“I'm the one who said they need to do something before they run out of money and you all complained and now it happens and you're all happy about it. Great logic” This logic, biotek, is called healthy corporate finances. Everyone knows the company needs to have strong finances before entering into any deal with pharma. Not just Sernova, any company.

 
Bullboard Posts